Genomma Lab Internacional, S.A.B. de C.V.

BMV:LAB B Voorraadrapport

Marktkapitalisatie: Mex$25.0b

Genomma Lab Internacional. de Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Genomma Lab Internacional. de heeft een totaal eigen vermogen van MX$11.2B en een totale schuld van MX$6.6B, wat de schuld-eigenvermogensverhouding op 59.1% brengt. De totale activa en totale passiva bedragen respectievelijk MX$23.5B en MX$12.4B. De EBIT Genomma Lab Internacional. de is MX$3.7B waardoor de rentedekking 4.2 is. Het heeft contanten en kortetermijnbeleggingen van MX$1.8B.

Belangrijke informatie

59.1%

Verhouding schuld/eigen vermogen

Mex$6.59b

Schuld

Rente dekkingsratio4.2x
ContantMex$1.83b
AandelenMex$11.15b
Totaal verplichtingenMex$12.36b
Totaal activaMex$23.51b

Recente financiële gezondheidsupdates

Recent updates

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Oct 17
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Calculating The Intrinsic Value Of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)

Sep 11
Calculating The Intrinsic Value Of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)

With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For

Jul 12
With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For

These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Jan 29
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Nov 07
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Mar 31
Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Feb 24
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Dec 07
Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Sep 24
Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Aug 01
Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Jul 27
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Mar 22
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Feb 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Nov 24
Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Sep 08
Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Jun 10
Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

May 24
Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

May 06
Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Mar 13
Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Feb 19
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Feb 02
Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

Jan 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Dec 28
What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Dec 10
Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MX$12.2B ) LAB B } overtreffen de korte termijn passiva ( MX$6.7B ).

Langlopende schulden: De kortetermijnactiva LAB B ( MX$12.2B ) overtreffen de langetermijnschulden ( MX$5.6B ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 42.7% ) LAB B wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van LAB B is de afgelopen 5 jaar gedaald van 74.3% naar 59.1%.

Schuldendekking: De schuld van LAB B wordt goed gedekt door de operationele kasstroom ( 39% ).

Rentedekking: De rentebetalingen op de schuld van LAB B worden goed gedekt door EBIT ( 4.2 x dekking).


Balans


Ontdek gezonde bedrijven